Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials

The objective of this analysis was to determine if there are sex differences with esketamine for treatment-resistant depression (TRD). Post hoc analyses of three randomized, controlled studies of esketamine in patients with TRD (TRANSFORM-1, TRANSFORM-2 [18–64 years], TRANSFORM-3 [≥ 65 years]) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Robyn R., Freeman, Marlene P., Kornstein, Susan G., Cooper, Kimberly, Daly, Ella J., Canuso, Carla M., Nicholson, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921149/
https://www.ncbi.nlm.nih.gov/pubmed/34973081
http://dx.doi.org/10.1007/s00737-021-01185-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921149/
https://www.ncbi.nlm.nih.gov/pubmed/34973081
http://dx.doi.org/10.1007/s00737-021-01185-6

Ejemplares similares